Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. I. Inhibition by RP-3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats
(Q70660992)
scientific article published on 01 May 1993
scientific article published on 01 May 1993
Language: